Rankings
▼
Calendar
ORKA Q4 2019 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ORKA
Oruka Therapeutics, Inc.
$1B
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$24,000
Operating Income
-$1M
Net Income
-$1M
EPS (Diluted)
$-9.23
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$1M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$9M
Total Liabilities
$926,000
Stockholders' Equity
$8M
Cash & Equivalents
$8M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$24,000
-$5,000
-380.0%
Operating Income
-$1M
-$2M
+16.3%
Net Income
-$1M
-$1M
+17.7%
← FY 2019
All Quarters
Q1 2020 →